BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation announced today that EKOS and their Netherlands distributor, AngioCare BV, are supporting a Dutch multicentre randomized trial (DUET) designed to ...

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center ...

Ekos, a Bothell medical device maker whose catheter-based ultrasound devices are used to break up blood clots in legs, has been acquired by British pharmaceutical company BTG for $180 million. The ...

BOTHELL – Ekos Corp., which has spent more than a decade inventing ultrasound-enhanced catheters that can quickly break up blood clots, is ready to sell the device to doctors around the world. The ...

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — In patients with acute submassive pulmonary embolism, treatment with tissue plasminogen ...

Ekos co-founder Doug Hansmann spent the past nine years developing an ultrasound catheter to help doctors quickly dissolve blood clots in the legs, arms and brain. Now after several fits and starts -- ...

The addition of IVUS to a fixed-dose catheter thrombolysis regimen failed to facilitate thrombus resolution in patients with acute iliofemoral deep vein thrombosis in the BERNUTIFUL trial. The ...

For years, the standard treatment for patients with blood clots in veins deep in a limb has been blood thinners that stop the clots from getting bigger. Last month, though, the American College of ...

BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0 London, UK, 27 February 2017: BTG plc (LSE: BTG), the global specialist healthcare company, today announced U.S. Food and Drug ...

Randomized Controlled Multi-Center Trial Demonstrates Reduced Treatment Time and Drug Dose with EKOS vs. Catheter-Directed Thrombolysis in Peripheral Arterial Occlusions EKOS Corporation, a privately ...